Skip to main content
. 2019 May 6;19:33. doi: 10.1186/s12894-019-0453-9

Fig. 2.

Fig. 2

Breakdown of mutations and copy number alterations in DDR pathways. The overall proportion of mutations and copy number alterations were similar for localized and metastatic prostate cancer